So we are expanding government in the process of doing this.

We have heard from many stakeholders that the provisions that were put in place have limited FDA's ability.

Substantial equivalence does not necessarily equate clearance, and your own information that you sent to a company that receives a substantial equivalence determination, 'Please be advised the FDA's issuance of a substantial equivalence…

But one specific instance, of course, a shortage occurs right now today at any pharmacy across the country that an asthmatic cannot walk into a pharmacy and buy an over-the-counter asthma inhaler like they used to be able to before January…

I don't understand, why would you not issue a mandatory recall immediately?

We need to reauthorize the user fees by the end of June to assure continuity at the FDA and increase predictability for America's medical innovators and job creators.

It seems like we could do this if we just had the political will to take it.

My personal feeling is the Tax Code is not the proper means for achieving those.

I think that there is a lot of the American electorate, a lot of the American people, feel that simplifying the tax system should be one of our highest priorities.

Mr. Speaker, yesterday I had the opportunity over at the Supreme Court to witness the oral arguments on the individual mandate. I believe I could tell from the faces of the Justices that there was significant skepticism about this…

I thank the chairman for yielding. A lot of people have asked, if you're going to do a Republican budget, why do you even involve yourself in the President's new health care law? They've asked, Why is it necessary for the Republican budget…